(Q37759874)

22 August 2017

1 reference

title

Management of postpolio syndrome (English)

1 reference

22 August 2017

Henrik Gonzalez

1

1 reference

22 August 2017

Tomas Olsson

series ordinal

2

1 reference

22 August 2017

Kristian Borg

series ordinal

3

1 reference

22 August 2017

publication date

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

9

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

634-642

1 reference

Epidemiology of Neuromuscular Diseases, Including the Postpolio Sequelae, in a Swedish County

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Post-poliomyelitis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Characteristics and management of postpolio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

1 reference

7 January 2021

Post-polio muscle dysfunction 29th ENMC workshop 14-16 October 1994, Naarden, the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

An 8-year longitudinal study of muscle strength, muscle fiber size, and dynamic electromyogram in individuals with late polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Late changes in the motor unit after acute poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Motoneuron firing and isomyosin type of muscle fibres in prior polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Prior poliomyelitis-reduced capillary supply and metabolic enzyme content in hypertrophic slow-twitch (type I) muscle fibres

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Contractile properties in single muscle fibres from chronically overused motor units in relation to motoneuron firing properties in prior polio patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Epidemiology of the post-polio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Postpolio syndrome: poliovirus persistence is involved in the pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Pathogenetic mechanisms of post-polio syndrome: morphological, electrophysiological, virological, and immunological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

The postpolio syndrome: no evidence for poliovirus persistence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Virology of the post-polio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Spinal cord histopathology in long-term survivors of poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Intrathecal immune response in patients with the post-polio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Prior poliomyelitis-evidence of cytokine production in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Identification of novel candidate protein biomarkers for the post-polio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Elevated serum inflammatory markers in post-poliomyelitis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Absence of SMN gene deletion in post-polio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Fcgamma receptor IIIA polymorphism as a risk factor for acute poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Dynamic electromyography and muscle biopsy changes in a 4-year follow-up: study of patients with a history of polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Nonparalytic polio and postpolio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Electrophysiologic and histologic studies in clinically unaffected muscles of patients with prior paralytic poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Methods for estimating numbers of motor units in biceps-brachialis muscles and losses of motor units with aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

How to interpret normal electromyographic findings in patients with an alleged history of polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Impact of age and co-morbidity on the functioning of patients with sequelae of poliomyelitis: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

SF36 physical functioning scale and 2-minute walk test advocated as core qualifiers to evaluate physical functioning in patients with late-onset sequelae of poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Impairment, disability, handicap and participation in post-poliomyelitis subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Disability and functional assessment in former polio patients with and without postpolio syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Distress in everyday life in people with poliomyelitis sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Disability in a 4-year follow-up study of people with post-polio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Perceived health and physical functioning in postpoliomyelitis syndrome: a 6-year prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Disability and quality of life in individuals with postpolio syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Coming to terms with the shift in one's capabilities: a study of the adaptive process in persons with poliomyelitis sequelae.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Life-long morbidity among Danes with poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Changes in strength over time among polio survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

The course of functional status and muscle strength in patients with late-onset sequelae of poliomyelitis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Reduction in thigh muscle cross-sectional area and strength in a 4-year follow-up in late polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Early and late losses of motor units after poliomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Electrophysiological findings in a cohort of old polio survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Muscle strength in postpolio patients: a prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Relationships between motor impairments and activity limitations in patients with neuromuscular disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Actual and perceived activity levels in polio survivors and older controls: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Perceived participation in life situations in persons with late effects of polio.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

How is walking speed related to muscle strength? A study of healthy persons and persons with late effects of polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

A 15-year follow-up of neuromuscular function in patients with prior poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Risk of falling: Predictors based on reduced strength in persons previously affected by polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Fatigue in post-poliomyelitis syndrome: association with disease-related, behavioral, and psychosocial factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Muscular effects in late polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Fatigue of muscles weakened by death of motoneurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Electrophysiologic evaluation of muscle fatigue development and recovery in late polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Fatigue in polio survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Impact of post-polio-related fatigue on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Vitality among Swedish patients with post-polio: a physiological phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Pain in persons with postpolio syndrome: frequency, intensity, and impact

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Pain, physical activity, and disability in individuals with late effects of polio.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Perceived disability, fatigue, pain and measured isometric muscle strength in patients with post-polio symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Musculoskeletal pain in polio survivors and strength-matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Predictive factors and correlates for pain in postpoliomyelitis syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Analysis of long-standing nociceptive and neuropathic pain in patients with post-polio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Post-poliomyelitis sequelae: A pathophysiologic basis for management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Late functional deterioration following paralytic poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Sleep-disordered breathing in fatigued postpoliomyelitis clinic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

The Norwegian Polio Study 1994: a nation-wide survey of problems in long-standing poliomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Late onset polio sequelae: Disabilities and handicaps in a population-based cohort of the 1956 poliomyelitis outbreak in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Dysphagia in patients with the post-polio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Laryngeal manifestations of postpoliomyelitis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Outcome of physiotherapy as part of a multidisciplinary rehabilitation in an unselected polio population with one-year follow-up: an uncontrolled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

The Role of Exercise in the Patient with Post‐Polio Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Energy demands of walking in persons with postpoliomyelitis syndrome: relationship with muscle strength and reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Submaximal exercise capacity and maximal power output in polio subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

1 reference

7 January 2021

Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Short-term effects of aerobic exercise on functional capacity, fatigue, and quality of life in patients with post-polio syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Dynamic water exercise in individuals with late poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

A Double‐Blind, Placebo‐Controlled Trial of High‐Dose Prednisone for the Treatment of Post‐Poliomyelitis Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

A Double‐Blind, Placebo‐Controlled, Trial of Amantadine for the Treatment, of Fatigue in Patients with the, Post‐Polio Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Effects of resistance training in combination with coenzyme Q10 supplementation in patients with post-polio: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Effect of intravenous immunoglobulin in patients with post-polio syndrome -- an uncontrolled pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Postpolio syndrome and anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Effect of carbon-composite knee-ankle-foot orthoses on walking efficiency and gait in former polio patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Oxygen consumption, oxygen cost and physiological cost index in polio survivors: a comparison of walking without orthosis, with an ordinary or a carbon-fibre reinforced plastic knee-ankle-foot orthosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

[Modern carbon fibre orthoses in the management of polio patients--a critical evaluation of the functional aspects]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Qualify of life and palliation predict survival in patients with chronic alveolar hypoventilation and nocturnal ventilatory support.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Bi-level positive airway pressure ventilation reduces the oxygen cost of breathing in long-standing post-polio patients on invasive home mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Lifestyle and late effects after poliomyelitis. A risk factor study of two populations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

A comparison of the effects of exercise and lifestyle modification on the resolution of overuse symptoms of the shoulder in polio survivors: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Group training in a pool causes ripples on the water: experiences by persons with late effects of polio

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

Poliomyelitis and the postpolio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970095-8

7 January 2021

10.1016/S1474-4422(10)70095-8

Identifiers

DOI

1 reference

22 August 2017

1 reference